OTTONELLO - Abuso dipendenza e deprivazione BDZ.pdf

More documents

Recommendations

Info

Annual USA ER Visits D.A.W.N. (Drug Abuse Warning Network) DATA 2004: 143,546 2005: 189,704 2006: 195,625 2007: 218,640 2008: 271,698
Epidemiology Life time use: 10-15% of men and women Chronic use USA: approximately 2% Denis C, et al: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings (Review). Cochrane 2009 1.2 million chronic users in the UK Ashton HC: The Treatment of Benzodiazepine Dependence. Addiction 1994;89:1535-1541
Page 1 and 2: Benzodiazepine Abuso Dipendenza e D
Page 5: History Benzodiazepines are “new
Page 9 and 10: Dependence 10,861 patients of the
Page 11 and 12: Allosteric Interactions
Page 14: Receptor mechanisms of Abuse Decre
Page 18 and 19: Dipendenza da BDZ Nel caso delle BD
Page 20 and 21: Changing definitions of dependence
Page 22 and 23: Tolerance developement Tolerance o
Page 24 and 25: Withdrawal Symptoms include many t
Page 26 and 27: Human No RCT Treatment Few uncont
Page 28 and 29: Grazie per l’ attenzione
Page 31 and 32: Acute Withdrawal Exclude life-thre
Page 33 and 34: Altri usi: BDZ e Alcohol-Withdrawal
Page 36: GABA Effects of Withdrawal
Page 42 and 43: Song J, et al. Benzodiazepine withd
Page 47: Xiang K, Tietz EI: Benzodiazepine-i
Page 53 and 54: Poorly described Syndrome Time cou
Page 55 and 56: Tex Med 1990;86:44 Alprazolam 1 mg
Page 58:
BZ Receptor Requirements γ subuni
show all

OTTONELLO - Abuso dipendenza e deprivazione BDZ.pdf

Create successful ePaper yourself

Delete template?

Save as template?